The Lipitor Medication Assistance Program (MAP) provides eligible patients with a reduced cost or free supply of the cholesterol-lowering medication atorvastatin, sold under the brand name Lipitor. According to the program's website [1], eligibility for the Lipitor MAP is as follows:

To be eligible, patients must have no insurance coverage or a high copayment for Lipitor, have difficulty affording the medication, be experiencing financial hardship, or have exhausted all other sources of financial assistance.

Additionally, patients must provide documentation of their income, insurance status, and medical records, including a prescription from a healthcare provider for Lipitor [1, DrugPatentWatch.com].

The program is sponsored by the manufacturer, Pfizer, in partnership with independent charity organizations, and the program's goal is to make Lipitor more accessible to eligible patients who cannot afford the full cost of the medication [1].

Patients can apply online through the Lipitor MAP website or by mail to initiate the application process. The application will be reviewed and a determination made regarding eligibility within a few days [1].

DrugPatentWatch.com [2] provides a comprehensive overview of the Lipitor Medication Assistance Program, including eligibility requirements, application process, and documentation needed.

References:

[1] https://www.lipitor.com/medication-assistance-program

[2] https://www.drugpatentwatch.com/medication-assistance-program/lipitor